2010
DOI: 10.1073/pnas.0912081107
|View full text |Cite
|
Sign up to set email alerts
|

Visualizing enveloping layer glycans during zebrafish early embryogenesis

Abstract: Developmental events can be monitored at the cellular and molecular levels by using noninvasive imaging techniques. Among the biomolecules that might be targeted for imaging analysis, glycans occupy a privileged position by virtue of their primary location on the cell surface. We previously described a chemical method to image glycans during zebrafish larval development; however, we were unable to detect glycans during the first 24 hours of embryogenesis, a very dynamic period in development. Here we report an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
142
0
3

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 158 publications
(152 citation statements)
references
References 35 publications
(34 reference statements)
2
142
0
3
Order By: Relevance
“…The impressive aglycon malleability of OleD (17)(18)(19), the demonstrated ability to expand the sugar scope of this catalyst, and the demonstrated superior ability of Loki to also catalyze "forward" coupled transglycosylation reactions suggest a range of exciting opportunities. Examples include extending applications toward (i) modified nucleoside-based NDPs (3) (reminiscent of the kinase "bump and hole" strategies) (38); (ii) specific sugardrug or sugar-natural product pairings (39)(40)(41); (iii) a broadened scope of deoxy, dideoxy, and/or uniquely functionalized sugars (e.g., sugars bearing amino-, N-akyl, O-alkyl, C-alkyl-, nitro, nitroso-, thio-modifications) (2,4,7,10,15,18,19); and (iv) other important biomolecules (e.g., proteins, polysaccharides) (42)(43)(44)(45).…”
Section: Preliminary Assessment Of Loki In a Model Coupled Forward Rementioning
confidence: 99%
“…The impressive aglycon malleability of OleD (17)(18)(19), the demonstrated ability to expand the sugar scope of this catalyst, and the demonstrated superior ability of Loki to also catalyze "forward" coupled transglycosylation reactions suggest a range of exciting opportunities. Examples include extending applications toward (i) modified nucleoside-based NDPs (3) (reminiscent of the kinase "bump and hole" strategies) (38); (ii) specific sugardrug or sugar-natural product pairings (39)(40)(41); (iii) a broadened scope of deoxy, dideoxy, and/or uniquely functionalized sugars (e.g., sugars bearing amino-, N-akyl, O-alkyl, C-alkyl-, nitro, nitroso-, thio-modifications) (2,4,7,10,15,18,19); and (iv) other important biomolecules (e.g., proteins, polysaccharides) (42)(43)(44)(45).…”
Section: Preliminary Assessment Of Loki In a Model Coupled Forward Rementioning
confidence: 99%
“…Finally, the SPAAC was investigated on more complex living system: mice [82]. In this study, the "chemical reporters" were the unnatural azido-sugar Ac 4 ManNAz and several cyclooctynes ( Figure 48) have been used, conjugated to a small peptide (FLAG).…”
Section: The Impact Of Spaacmentioning
confidence: 99%
“…The most advanced work on SPAAC labeling was conducted by Bertozzi et al [82] as they managed to directly visualize glycans in membrane cells of zebrafish embryos during their development. Injection of Ac 4 GalNAz combined with a DIFO-fluorophore conjugates labeling led to very interesting observations about O-glycans distribution in zebrafish embryos.…”
Section: The Impact Of Spaacmentioning
confidence: 99%
“…This technique involves the incorporation of chemically modified sugars, such as azide-or alkyne-modified sugars, into cellular glycans via a normal biosynthetic pathway, and its subsequent detection with a probe, such as a FLAG-tag, biotin or fluorescent molecules [4][5][6] . Furthermore, application of this method for imaging of specific sugars in living cells and organisms has provided insights into the spatiotemporal expression and trafficking of glycans [7][8][9][10] . On the other hand, the currently available techniques face certain technical limitations, including the lack of selectivity, that is, there is no established method to detect a 'glycoform' (a protein with a specific glycan modification) of a given glycoprotein.…”
mentioning
confidence: 99%